Trial data on epcoritamab plus rituximab-lenalidomide, a novel CELMoD agent, late-line CAR-T cell therapy, and selecting ...

Dr Mark Kris breaks down the lazertinib-amivantamab data, noting that the combo shows benefit but fails to address key ...

Despite a mismatch in the dominant strain and the flu vaccine this year, HCPs are still central in advising patients to receive shot, likely reducing severity of disease.

Drs Harrington and Gibson’s annual review of cardiovascular medicine: ACS guidelines, antiplatelet management, GLP-1s, and ...

Dr Kami Maddocks reflects on fresh data, such as the new epcoritamab combo approval, evolving CD19 sequencing data, and ...

Insights from ASH 2025, including anticipated presentations, key takeaways, and how emerging research in paroxysmal nocturnal ...

The progress in understanding the pathophysiology of hidradenitis suppurativa appears to be leading to treatment strategies ...

Christmas traditions such as decorating a tree and singing not only lift spirits but also boost immunity by triggering immune ...

Semaglutide use is linked to fewer hospitalizations and fewer days in the hospital for patients with cardiovascular disease ...

Edward S. Cooper, MD, the American Heart Association’s first Black president, leaves behind an indelible mark on stroke ...

Menopause hormone therapy neither increases nor decreases the risk for dementia or mild cognitive impairment in ...

Growth hormone replacement therapy improves physical fitness, lifestyle habits, and quality of life in children with growth ...